| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 148, Issue 5 1493-1498, Copyright © 1992 by American Association of Immunologists
ARTICLES |
LH Kasper, IA Khan, KH Ely, R Buelow and JC Boothroyd
Department of Medicine, Dartmouth Medical School, Hanover, NH 03756.
The importance of CD8+ T cells in immunity against Toxoplasma gondii is now well recognized. The mechanism by which these CD8+ T cells are able to confer this immunity is not yet understood. To examine the Ag specificity of this response, immune splenocytes from mice immunized with p30, a major surface parasite Ag, were evaluated for their ability to lyse peritoneal macrophages infected with three different strains of T. gondii. Macrophages infected with either the RH or P wild-type strain tachyzoites were lysed at varying E:T ratios by nylon wool nonadherent immune splenocytes whereas macrophages infected with a p30- deficient mutant (B mutant) of the P strain were not. The gene encoding p30 for the wild type and B mutant were amplified by the polymerase chain reaction. This revealed a nonsense mutation in the B mutant such that its primary translation product is predicted to be about two- thirds the size of the wild-type p30 molecule. mAb depletion studies indicate that the cytotoxic effect of the immune splenocytes is mediated by the CD8+ T cell population. Peritoneal macrophages infected with the three different strains (RH, P wild type, B mutant) from mice genetically restricted were not lysed by the immune CD8+ effector cell population. A cloned line (C3) of p30 Ag-specific CD8+ T cells exhibited significant cytotoxicity against syngeneic peritoneal macrophages infected with either the RH or P strain tachyzoites. There was no macrophage lysis observed by these CD8+ effector cells of either syngeneic macrophages infected with the B mutant or nonsyngeneic macrophages infected with the three different tachyzoite strains.
This article has been cited by other articles:
|
|
 |
|
  F. Dzierszinski, M. Pepper, J. S. Stumhofer, D. F. LaRosa, E. H. Wilson, L. A. Turka, S. K. Halonen, C. A. Hunter, and D. S. Roos Presentation of Toxoplasma gondii Antigens via the Endogenous Major Histocompatibility Complex Class I Pathway in Nonprofessional and Professional Antigen-Presenting Cells Infect. Immun., November 1, 2007; 75(11): 5200 - 5209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lu, S. Huang, M. S. Hu, and L. H. Kasper Experimental Ocular Toxoplasmosis in Genetically Susceptible and Resistant Mice Infect. Immun., August 1, 2005; 73(8): 5160 - 5165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-J. Gubbels, B. Striepen, N. Shastri, M. Turkoz, and E. A. Robey Class I Major Histocompatibility Complex Presentation of Antigens That Escape from the Parasitophorous Vacuole of Toxoplasma gondii Infect. Immun., February 1, 2005; 73(2): 703 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Scorza, S. D'Souza, M. Laloup, J. Dewit, J. De Braekeleer, H. Verschueren, M. Vercammen, K. Huygen, and E. Jongert A GRA1 DNA Vaccine Primes Cytolytic CD8+ T Cells To Control Acute Toxoplasma gondii Infection Infect. Immun., January 1, 2003; 71(1): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haumont, L. Delhaye, L. Garcia, M. Jurado, P. Mazzu, V. Daminet, V. Verlant, A. Bollen, R. Biemans, and A. Jacquet Protective Immunity against Congenital Toxoplasmosis with Recombinant SAG1 Protein in a Guinea Pig Model Infect. Immun., September 1, 2000; 68(9): 4948 - 4953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Prigione, P. Facchetti, L. Lecordier, D. Deslee, S. Chiesa, M.-F. Cesbron-Delauw, and V. Pistoia T Cell Clones Raised from Chronically Infected Healthy Humans by Stimulation with Toxoplasma gondii Excretory-Secretory Antigens Cross-React with Live Tachyzoites: Characterization of the Fine Antigenic Specificity of the Clones and Implications for Vaccine Development J. Immunol., April 1, 2000; 164(7): 3741 - 3748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Khan and L. Casciotti IL-15 Prolongs the Duration of CD8+ T Cell-Mediated Immunity in Mice Infected with a Vaccine Strain of Toxoplasma gondii J. Immunol., October 15, 1999; 163(8): 4503 - 4509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Khan, J. D. Schwartzman, L. H. Kasper, and M. Moretto CD8+ CTLs Are Essential for Protective Immunity Against Encephalitozoon cuniculi Infection J. Immunol., May 15, 1999; 162(10): 6086 - 6091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Ely, L. H. Kasper, and I. A. Khan Augmentation of the CD8+ T Cell Response by IFN-{gamma} in IL-12-Deficient Mice During Toxoplasma gondii Infection J. Immunol., May 1, 1999; 162(9): 5449 - 5454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Hu, J. D. Schwartzman, G. R. Yeaman, J. Collins, R. Seguin, I. A. Khan, and L. H. Kasper Fas-FasL Interaction Involved in Pathogenesis of Ocular Toxoplasmosis in Mice Infect. Immun., February 1, 1999; 67(2): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Y. Denkers and R. T. Gazzinelli Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection Clin. Microbiol. Rev., October 1, 1998; 11(4): 569 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Khan, T. Matsuura, and L. H. Kasper Inducible Nitric Oxide Synthase Is Not Required for Long-Term Vaccine-Based Immunity Against Toxoplasma gondii J. Immunol., September 15, 1998; 161(6): 2994 - 3000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Silva, R. T. Gazzinelli, D. A. O. Silva, E. A. V. Ferro, L. H. Kasper, and J. R. Mineo Expression of Toxoplasma gondii-Specific Heat Shock Protein 70 during In Vivo Conversion of Bradyzoites to Tachyzoites Infect. Immun., August 1, 1998; 66(8): 3959 - 3963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Deckert-Schluter, H. Bluethmann, A. Rang, H. Hof, and D. Schluter Crucial Role of TNF Receptor Type 1 (p55), But Not of TNF Receptor Type 2 (p75), in Murine Toxoplasmosis J. Immunol., April 1, 1998; 160(7): 3427 - 3436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Seeber, J. Dubremetz, and J. Boothroyd Analysis of Toxoplasma gondii stably transfected with a transmembrane variant of its major surface protein, SAG1 J. Cell Sci., January 1, 1998; 111(1): 23 - 29. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
